Cutting-edge research presented at ACR Convergence 2024 unveils Nav1.7 sodium channels as a promising target to treat ...

A new study published in the journal of PLOS One found that increased addition of sugar elevated the risk of osteoarthritis, ...

The global osteoarthritis therapeutics market size is calculated at USD 9.91 billion in 2024 and is expected to reach around USD 24.34 billion by 2034, growing at a solid CAGR of 9.4% from 2024 to ...

In this randomized controlled trial, total hip replacement (THR) was superior to resistance training in improving hip pain ...

This improves joint function and movement, which can help restore your ability to participate in regular activities.Prognosis ...

Doron Therapeutics, a clinical-stage biotech company focusing on degenerative musculoskeletal conditions, today announced it ...

If you have osteoarthritis, you know how much joint pain can affect your daily life. Osteoarthritis is the most common type of arthritis, afflicting 33 million U.S. adults, according to the Centers ...

The global knee hyaluronic acid injections market generated USD 2.09 billion in revenue in 2023, and is projected to grow to USD 3.40 billion by 2033, reflecting a CAGR of 5% over the forecast period.

Both studies were presented at the American College of Rheumatology (ACR) annual meeting.

Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), ...

The annual meeting of the American College of Rheumatology was held this year from Nov. 14 to 19 in Washington, D.C., and ...

BACKPACKOriginal ArticleTitle:Dual-function natural products: Farnesoid X receptor agonist/inflammation inhibitor for ...